Koshinski Asset Management, Inc. Global Blood Therapeutics, Inc. Transaction History

Koshinski Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$22.3 - $37.39 $44,600 - $74,780	-2,000 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$24.9 - $40.26 $24,900 - $40,260	1,000 Added 100.0%	2,000 $58.5 Million
Q3 2021 Oct 12, 2021	BUY	$25.48 - $37.34 $25,480 - $37,340	1,000 New	1,000 $25,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.